Kardiológus 2013. március

Irodalom 1. CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348, 1329-1339.

2. Bhatt, D.L. és mtsai. REACH Investigation: Presented at: American College of Cardiology Annual Scientific Session; March 8, 2005, Orlando, FL. Abstract 1127-1196.

3. Kannel, W.B.: The demographics of claudication and the aging of the American population. Vasc.

Med., 1996, 1, 60-64.

4. Kannel, W.B. és mtsai: Intermittent claudication: incidence in the Framingham Study. Circulation, 1970, 41, 875-883.

5. Fowkes, F.G. és mtsai: Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int. J. Epidemiol., 1991, 20, 384-392.

6. Meijer, W.T. és mtsai: Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler.

Thromb. Vasc. Biol., 1998, 18 (2), 185-192.

7. Hirsch, A.T. és mtsai: Peripheral arterial disease detection, awareness and treatment in primary care. JAMA, 2001, 286, 1317-1326.

8. Leng, G.C., Fowkes, F.G.R., Lee, A.J. és mtsai: Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. Br. Med. J., 1996, 313, 1440-1444.

9. Kornitzer, M., Dramaix, M., Sobolski, J. és mtsai: Ankle-arm pressure index in asymptomatic middle aged males: an independent predictor of ten year coronary heart disease mortality.

Angiology, 1995, 46, 211-219.

10. Criqui, M.H., Langer, R.D., Fronek, A. és mtsai: Mortality over a period of 10 years in patients with peripheral arterial disease. N. Engl. J. Med., 1992, 326, 381-386.

11. Ostergren, J., Sleight, P., Dagenais, G. and HOPE study investigators: Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur. Heart J., 2004, 25 (1), 17-22.

12. Inoue, T., Node, K.: Vascular failure: A new clinical entity for vascular disease. J. Hypertens., 2006, 24 (11), 2121-2130. Review.

13. Kannel, W.B. és mtsai: Update on some epidemiological features of intermittent claudication: the Framingham study. J. Am. Geriatr. Soc., 1985, 33, 13-18.

14. Meijer, W.T. és mtsai: Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler.

Thromb. Vasc. Biol., 1998, 18 (2), 185-192.

15. Fowkes, F.G. és mtsai: Smoking, lipids, glucose intolerance and blood pressure as risk factors for peripheral atherosclerosis compared with ischaemic heart disease in the Edinburgh Artery Study.

Am. J. Epidemiol., 1992, 135, 331-340.

16. Price, J.F. és mtsai: Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur. Heart J., 1999, 20, 344-353.

17. Steven, P. és mtsai: Peripheral Arterial Disease in Patients With Diabetes JACC, 2006, 47, 921-929.

18. Murabito, és mtsai: Intermittent claudication. A risk profile from the Framingham Heart Study.

Circulation, 1997, 96, 44-49.

19. Newman, A.B. és mtsai: Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation, 1993, 88, 837-845.

20. Newman, A.B. és mtsai: Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation, 1993, 88, 837-845.

56